Nucleotide excision repair gene polymorphisms and hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study

被引:0
|
作者
Yin, Huimin [1 ]
Wang, Xianqiang [2 ]
Zhang, Shouhua [3 ]
He, Shaohua [4 ]
Zhang, Wenli [1 ]
Lu, Hongting [5 ]
Wang, Yizhen [6 ]
He, Jing [1 ]
Zhou, Chunlei [7 ]
机构
[1] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Pediat Surg, Guangzhou Inst Pediat,Guangdong Prov Key Lab Res S, 9 Jinsui Rd, Guangzhou 510623, Peoples R China
[2] Chinese Peoples Liberat Army PLA Gen Hosp, Dept Pediat Surg, Senior Dept Pediat, Ctr 7, Beijing 100000, Peoples R China
[3] Jiangxi Prov Childrens Hosp, Dept Gen Surg, Nanchang 330006, Peoples R China
[4] Fujian Med Univ, Dept Pediat Surg, Shengli Clin Med Coll, Fuzhou 350001, Peoples R China
[5] Qingdao Women & Childrens Hosp, Dept Pediat Surg, Qingdao 266000, Peoples R China
[6] Anhui Prov Childrens Hosp, Dept Pathol, Hefei 230051, Peoples R China
[7] Nanjing Med Univ, Dept Pathol, Childrens Hosp, 2 Guangzhou Rd, Nanjing 210008, Peoples R China
关键词
Nucleotide excision repair; polymorphisms; hepatoblastoma; susceptibility; CANCER-RISK; ASSOCIATION; EXPRESSION; COMPLEX; GROWTH; IASPP;
D O I
10.21147/j.issn.1000-9604.2024.03.06
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Nucleotide excision repair (NER) plays a vital role in maintaining genome stability, and the effect of NER gene polymorphisms on hepatoblastoma susceptibility is still under investigation. This study aimed to evaluate the relationship between NER gene polymorphisms and the risk of hepatoblastoma in Eastern Chinese Han children. Methods: In this five-center case-control study, we enrolled 966 subjects from East China (193 hepatoblastoma patients and 773 healthy controls). The TaqMan method was used to genotype 19 single nucleotide polymorphisms (SNPs) in NER pathway genes, including ERCC1 , XPA , XPC , XPD , XPF , and XPG . Then, multivariate logistic regression analysis was performed, and odds ratios (ORs) and 95% confidence intervals (95% CIs) were utilized to assess the strength of associations. Results: Three SNPs were related to hepatoblastoma risk. XPC rs2229090 and XPD rs3810366 significantly contributed to hepatoblastoma risk according to the dominant model (adjusted OR=1.49, 95% CI=1.07 -2.08, P=0.019; adjusted OR=1.66, 95% CI=1.12 -2.45, P=0.012, respectively). However, XPD rs238406 conferred a significantly decreased risk of hepatoblastoma under the dominant model (adjusted OR=0.68, 95% CI=0.49 -0.95; P=0.024). Stratified analysis demonstrated that these significant associations were more prominent in certain subgroups. Moreover, there was evidence of functional implications of these significant SNPs suggested by online expression quantitative trait loci (eQTLs) and splicing quantitative trait loci (sQTLs) analysis. Conclusions: In summary, NER pathway gene polymorphisms ( XPC rs2229090, XPD rs3810366, and XPD rs238406) are significantly associated with hepatoblastoma risk, and further research is required to verify these findings.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] HMGA2 Polymorphisms and Hepatoblastoma Susceptibility: A Five-Center Case-Control Study
    Li, Li
    Zhuo, Zhenjian
    Yang, Zhen
    Zhu, Jinhong
    He, Xiaoli
    Yang, Zhonghua
    Zhang, Jiao
    Xin, Yijuan
    He, Jing
    Zhang, Tiesong
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2020, 13 : 51 - 57
  • [2] LMO family gene polymorphisms and Wilms tumor susceptibility in Chinese children: a five-center case-control study
    Fu, Wen
    Deng, Linqing
    Yan, Xiaosong
    Hua, Rui-Xi
    Zhang, Jiao
    Zhou, Haixia
    Deng, Changmi
    Li, Suhong
    Cheng, Jiwen
    Ruan, Jichen
    He, Jing
    Liu, Guochang
    BMC CANCER, 2024, 24 (01)
  • [3] YTHDC1 gene polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study
    Lin, Ao
    Hua, Rui-Xi
    Zhou, Mingming
    Fu, Wen
    Zhang, Jiao
    Zhou, Haixia
    Li, Suhong
    Cheng, Jiwen
    Zhu, Jinhong
    Xia, Huimin
    Liu, Guochang
    He, Jing
    GENE, 2021, 783
  • [4] YTHDC1gene polymorphisms and hepatoblastoma susceptibility in Chinese children: A seven-center case-control study
    Chen, Huitong
    Li, Yong
    Li, Li
    Zhu, Jinhong
    Yang, Zhonghua
    Zhang, Jiao
    Li, Suhong
    Xin, Yijuan
    Xia, Huimin
    He, Jing
    JOURNAL OF GENE MEDICINE, 2020, 22 (11)
  • [5] ALKBH5 gene polymorphisms and Wilms tumor risk in Chinese children: A five-center case-control study
    Hua, Rui-Xi
    Liu, Jiabin
    Fu, Wen
    Zhu, Jinhong
    Zhang, Jiao
    Cheng, Jiwen
    Li, Suhong
    Zhou, Haixia
    Xia, Huimin
    He, Jing
    Zhuo, Zhenjian
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (06)
  • [6] WDR4 gene polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study
    Deng, Linqing
    Hua, Rui-Xi
    Deng, Changmi
    Zhu, Jinhong
    Zhang, Zhengtao
    Cheng, Jiwen
    Zhang, Jiao
    Zhou, Haixia
    Li, Suhong
    Ruan, Jichen
    Liu, Guochang
    He, Jing
    Fu, Wen
    JOURNAL OF CANCER, 2023, 14 (08): : 1293 - 1300
  • [7] METTL3polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study
    Lin, Ao
    Zhou, Mingming
    Hua, Rui-Xi
    Zhang, Jiao
    Zhou, Haixia
    Li, Suhong
    Cheng, Jiwen
    Xia, Huimin
    Fu, Wen
    He, Jing
    JOURNAL OF GENE MEDICINE, 2020, 22 (11)
  • [8] Impact of YTHDF1 gene polymorphisms on Wilms tumor susceptibility: A five-center case-control study
    Liu, Yanfei
    Lin, Huiran
    Hua, Rui-Xi
    Zhang, Jiao
    Cheng, Jiwen
    Li, Suhong
    Zhou, Haixia
    Zhuo, Zhenjian
    Bian, Jun
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (08)
  • [9] Genetic variants in XPD gene and glioma susceptibility in Chinese children: A multicenter case-control study
    Chen, Yong-Ping
    Liao, Yuxiang
    Yuan, Li
    Huang, Xiao-Kai
    Ruan, Ji-Chen
    Lin, Hui-Ran
    Miao, Lei
    Zhuo, Zhen-Jian
    CANCER INNOVATION, 2022, 1 (01): : 70 - 79
  • [10] Polymorphisms in METTL3 gene and hepatoblastoma risk in Chinese children: A seven-center case-control study
    Chen, Huitong
    Duan, Fei
    Wang, Mi
    Zhu, Jinhong
    Zhang, Jiao
    Cheng, Jiwen
    Li, Li
    Li, Suhong
    Li, Yong
    Yang, Zhonghua
    Xia, Huimin
    Niu, Huizhong
    He, Jing
    GENE, 2021, 800